2Zangwill K, Droge J, Mendelman P, et al.Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis,2004,23: 189-197.
3Zangwill K, Droge J, Mendelman P, et al. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Accepted for Publication Dec, 2003.12.
5Bergen R, Black S, Shine FH, et al. Safety of cold - adopted live attenuated influenza vaccine in a large cohort of children and adolescents.Pediatr Infect Dis, 2004, 23: 138- 144.
6Block S, Caiv TT. New data on influenza vaccines in children. Pediatr Infect Dis, 2004, 23: 85.
7Mazrou A, Soong T, Bjomson G, et al. Comparison of adverse reactions to whole - virion and split - virion influenza vaccines in hospital personnel. CMAJ, 1991, 145: 213-218.
9Neuzil KM, Dupont WD, Wright PF, et al. Efficacy of inactivated and cold - adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.
10Gonzalez M, Pirez MC, Ward E, et al. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child, 2000,83 : 488 - 491.
2Spila-Alegiani S, Salrnaso S, Rota MC, et al. Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Vaccine, 1999,17:1898-1904.
3Gerdil C. The annual production cycle for influenza vaccine.Vaccine, 2003,21 : 1776-1779.
